Help Find A Cure For ALS!

WELCOME TO THE ANGEL FUND FOR ALS RESEARCH

The Angel Fund for ALS Research (Angel Fund, Inc.) is an independent non-profit charity (04-3478977) dedicated to supporting ALS (Lou Gehrig’s Disease) investigations at the Cecil B. Day Laboratory for Neuromuscular Research at UMass Medical School in Worcester, MA, internationally recognized for its ground-breaking work in the fight against this devastating illness.

The Angel Fund is special.

We are not a national charity – we are local. We have very low overhead and administrative costs.

Why are they so passionate?

Because most have lived through the heartbreak of seeing their loved one live with ALS and lose their battle to this horrific disease.


Dr. Daryl Bosco named Co-Scientific Advisor

Dr. Daryl Bosco has loined The Angel Fund as Co-Scientific Advisor. Dr. Bosco will join Dr. Robert H. Brown, Jr.in this position.

Our mission is to support ALS (Lou Gehrig’s Disease) research and scientific investigations at the Cecil B. Day Laboratory by raising funds through events, campaigns, foundation grants and numerous other community outreach activities, to aid in finding a cause, treatment and cure for ALS.

Our Non-Profit Setup

Our offices are located in the law firm of Nigro Pettipet and Lucas, courtesy of Directors Jan and Eugene Nigro. Angel Fund President Rich Kennedy and the board members are not paid. As a result, it means we have very low overhead and administrative costs so more money goes to research. We are proud to say that 92% of funds expended goes to research.

  • No rent
  • No utility bills
  • No high paid executives

Pilot human study shows novel treatment suppresses mutant ALS gene

(Wakefield, MA) – A clinical trial funded by The Angel Fund for ALS Research has shown significant progress in suppressing expression of the most commonly mutated ALS gene, C9ORF72 (C9). The C9 gene mutation, a lengthy expansion of a repeated segment of six molecules of DNA, causes both familial ALS and frontotemporal dementia. The results of the human trial, initiated and led by Drs. Robert H. Brown and Jonathan Watts at UMass Chan Medical School, were published in Nature Medicine.

 

Latest News Entries

January 9, 2022
News

ALS Research Update

Research Update By Dr. Robert H. Brown, Jr. Prospects for ALS – The View at Year’s End – 2021 Remarkably, today we said farewell to 2021; this is an appropriate time to look back on recent developments in ALS research. It can truly be said that there has been meaningful progress in the quest to […]

December 28, 2021
News

Groundbreaking News for ALS Research

Pilot human study shows novel treatment suppresses mutant ALS gene The Angel Fund for ALS Research provides major funding (Wakefield, MA) – A clinical trial funded by The Angel Fund for ALS Research has shown significant progress in suppressing expression of the most commonly mutated ALS gene, C9ORF72 (C9). The C9 gene mutation, a lengthy […]

September 25, 2021
News

1st Annual Cornhole Tourmament

On a beautiful afternoon in the historic North End of Boston, friends and family gathered at the first annual “Cornhole to Strike Out ALS” event on Saturday, September 11. The event was organized by Ryan Charter and hosted at Copp’s Hill Terrace in Boston overlooking Boston Harbor and the Bunker Hill Monument. “This horrible disease […]

Our Partners

Angel Fund supporters make a difference in fighting ALS, and you can be one of them.